Disease-Modifying Therapy in Multiple Sclerosis: Strategies for Optimizing Management

    July 2002 in “ The Neurologist ”
    Elliot M. Frohman, Ted Phillips, Kristen Kokel … Michael K. Racke
    Studysummary This article reviews the challenges of using disease-modifying therapy for multiple sclerosis and offers strategies to improve treatment adherence and manage adverse effects, but reports no new clinical findings.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on journals.lww.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Multiple Sclerosis: Side Effects of Interferon Beta Therapy and Their Management Neurology · 1999